Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...

Kyocera Corporation (President: Hideo Tanimoto; “Kyocera”)(TOKYO: 6971) announced that it has developed a new meta-lens that ...

CMMC Phase 1 began Nov. 10, and major defense primary contractors are already demanding compliance from their suppliers.

The $960 million Stellant Systems acquisition expands TransDigm’s aerospace and defense electronics portfolio.

A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...

A device smaller than a grain of dust may help unlock the kind of quantum computers people have only dreamed about. Built on ...

Curious to find out all the requirements for the different phases of the 2nd Expedition Project? Here is what players need to ...

Impressively, the unit registered the lowest frequency loss of any chip to date. Specifically, the engineers noted that the new chip was 15x more stable and 100x more efficient in terms of microwave ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ...

Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...